Details of the Drug Combinations
General Information of This Drug (ID: DMTBGW8)
| Drug Name | |||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Synonyms | 
                                         
                        VDN; Levitra (TN); VARDENAFIL, LEVITRA; Vardenafil (INN); 1-((3-(3,4-Dihydro-5-methyl-4-oxo-7-propylimidazo(5,1-f)-as-triazin-2-yl)-4-ethoxyphenyl)sulfonyl)-4-ethylpiperazine; 2-(2-Ethoxy-5-(4-ethylpiperazin-1-yl-1-sulfonyl)phenyl)-5-methyl-7-propyl-3H-imidazo(5,1-f)(1,2,4)triazin-4-one; 2-[2-ethoxy-5-(4-ethylpiperazin-1-yl)sulfonylphenyl]-5-methyl-7-propyl-1H-imidazo[5,1-f][1,2,4]triazin-4-one; 2-{2-ETHOXY-5-[(4-ETHYLPIPERAZIN-1-YL)SULFONYL]PHENYL}-5-METHYL-7-PROPYLIMIDAZO[5,1-F][1,2,4]TRIAZIN-4(1H)-ONE; 2-{2-ethoxy-5-[(4-ethylpiperazin-1-yl)sulfonyl]phenyl}-5-methyl-7-propylimidazo[5,1-f][1,2,4]triazin-4-ol
                        
                     
                                     | 
            ||||||||||||||||||||||||||
| Indication | 
                                                            
  | 
            ||||||||||||||||||||||||||
| Therapeutic Class | 
                     Antiimpotence Agents 
                 | 
            ||||||||||||||||||||||||||
| Drug Type | 
                     Small molecular drug 
                 | 
            ||||||||||||||||||||||||||
| Structure | 
                    ![]()  | 
            ||||||||||||||||||||||||||
| 3D MOL | 2D MOL | ||||||||||||||||||||||||||
List of Combinatorial Drugs (CBD) Containing This Drug
| 
                     1 Investigative Drug Combination(s) Consisting of This drug 
                                                Normalized Drug Combination Synergy Score 
                            
                                
                                Synergy scores were normalized using Min-Max Scaling to facilitate visual comparisons. 
                                                                        
  | 
            ||||||||||||||||||||||||||||||
| 
                     2 Clinical Trial Drug Combination(s) Consisting of This drug 
                                                                    
  | 
            ||||||||||||||||||||||||||||||
References

